VCYT
Veracyte IncHenter pris…
Værdiansættelse (TTM)
Kursudvikling
Kun 82 handelsdage i databasen. Viser al tilgængelig historik.
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 0,2 år
- Pris-dage
- 58
- Årsregnskaber
- 16
- Peers
- 0/0
- Valuation
- 2/6
- Fundamentals
- 8/8
- Datovindue
- 2026-02-17 til 2026-05-08
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Mangler ca. 9,8 års prishistorik før ideal/full.
- Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
- Kør compute-multiples for manglende valuation metrics.
Seneste assessment
VCYT vurderet 2026-06-10
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: Own P/E 48.1 vs peer median 12.6; premium is not clearly justified by growth or margin superiority.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 18.6.2026 | EASTHAM KARIN | — | ▼ SALG | -3.200 | -168.906 USD | sec |
| 11.6.2026 | EPSTEIN ROBERT S | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | EASTHAM KARIN | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | JONES EVAN/ FA | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | Miller Thomas F. | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | Bhanji Muna | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | Holstein Jens | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | Barr Eliav | — | · ANDET | 5.272 | — | sec |
| 11.6.2026 | Shafer David Brent | — | · ANDET | 5.272 | — | sec |
| 4.6.2026 | McGuire Annie | EVP, General Counsel | ▼ SALG | -1.400 | -69.029 USD | sec |
| 4.6.2026 | Stapley Marc | Chief Executive Officer | ◆ OPT. | 138.051 | 5.052.667 USD | sec |
| 4.6.2026 | Stapley Marc | Chief Executive Officer | ▼ SALG | -138.051 | -6.919.585 USD | sec |
| 4.6.2026 | Chambers Rebecca | Chief Financial Officer | ▼ SALG | -1.600 | -78.854 USD | sec |
| 4.6.2026 | Leite John | Global Chief Commercial Off | ▼ SALG | -13.975 | -699.732 USD | sec |
| 2.6.2026 | Leite John | Global Chief Commercial Off | · ANDET | -4.059 | -194.020 USD | sec |
| 2.6.2026 | Febbo Phillip G. | Chief Scientific & Med Officer | · ANDET | -3.730 | -178.294 USD | sec |
| 2.6.2026 | Wygant Jonathan | VP, Chief Accounting Officer | · ANDET | -1.361 | -65.056 USD | sec |
| 2.6.2026 | Stapley Marc | Chief Executive Officer | · ANDET | -9.012 | -430.774 USD | sec |
| 2.6.2026 | McGuire Annie | EVP, General Counsel | · ANDET | -3.292 | -157.358 USD | sec |
| 2.6.2026 | Chambers Rebecca | Chief Financial Officer | · ANDET | -3.693 | -176.525 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | 0,52 | 0,33 | +56.0% | +56.0% | Beat |
| 2025Q4 | 30.1.2026 | 0,53 | 0,41 | +29.8% | +29.8% | Beat |
| 2025Q3 | 30.10.2025 | 0,51 | 0,32 | +59.5% | +59.5% | Beat |
| 2025Q2 | 30.7.2025 | 0,44 | 0,30 | +48.5% | +48.5% | Beat |